Until Labs tackles the global organ shortage through reversible cryopreservation technology. The company develops advanced vitrification protocols and rewarming systems that prevent ice crystal damage, allowing biological tissues and organs to be stored indefinitely. Their mission is to build the infrastructure for true organ banking, eliminating the time constraints of transplant logistics. The approach compresses traditional R&D timelines, offering systemic cost reductions in therapeutic development and biological engineering.